Longitudinal impact of cross-clamp duration on postoperative sleep disturbance and quality of life in elderly cardiac surgery patients: a secondary analysis of the MINDDS trial

Objectives This study aimed to assess the enduring impact of cross-clamp duration on postoperative sleep disturbance and functional outcomes (up to 180 days) in cardiac surgery patients. Design This is a secondary analysis of data from a randomized, double-blind trial comparing dexmedetomidine to placebo for delirium prevention (Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep). Setting Data from patients recruited at a tertiary medical center in Boston, Massachusetts, between March 2017 and February 2022 were analyzed in January 2024. Participants The study included 394 patients aged ≥60 who underwent cardiac surgery with cardiopulmonary bypass. Interventions The primary exposure was cross-clamp time, while secondary exposures included surgical type [isolated coronary artery bypass graft (CABG) or not] and dexmedetomidine randomization. Measurements and main results The primary outcome was sleep quality, assessed using the PROMIS Sleep Disturbance questionnaire at 30, 90, and 180 days postoperatively. Secondary outcomes encompassed cognitive function and health-related quality of life in various domains. Sleep quality, measured by PROMIS scores, showed improvement over time, and did not differ based on cross-clamp duration (MD 0.74 points, 95% CI: −0.57, 2.07), procedure type (MD 2.14 points, 95% CI: 0.29, 3.99), or dexmedetomidine (MD 0.9 points, 95% CI: −1.33, 1.5). However, isolated CABG patients reported sleep disturbance at all time points. Notably, extended cross-clamp time (>90 min) significantly worsened the trajectories of mental health (90-day: MD −2.37 points, 95% CI: −4.35, −0.39; 180-day: MD −2.68 points, 95% CI: −4.62, −0.73) and applied cognition (180-day: MD: −2.59 points, 95% CI: −4.49, −0.68). Conclusion Regardless of the duration of the cross-clamp, sleep quality tends to improve over time following cardiac surgery. However, cross-clamp times that last longer than 90 min have been identified as a risk factor for self-reported declines in mental health and applied cognition.

Authors

Publication Details

Journal
Frontiers in Anesthesiology
Published
2025-01-22
DOI
https://doi.org/10.3389/fanes.2024.1483837
Primary Topic
Intensive Care Unit Cognitive Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Longitudinal impact of cross-clamp duration on postoperative sleep disturbance and quality of life in elderly cardiac surgery patients: a secondary analysis of the MINDDS trial

Ariel Mueller, Oluwaseun Akeju, Michael Brandon Westover, Jamie L. Sparling et al.
Frontiers in Anesthesiology
Intensive Care Unit Cognitive Disorders
article

Longitudinal impact of cross-clamp duration on postoperative sleep disturbance and quality of life in elderly cardiac surgery patients: a secondary analysis of the MINDDS trial

Ariel Mueller, Oluwaseun Akeju, Michael Brandon Westover, Jamie L. Sparling, Kwame Wiredu, Jason Zhensheng Qu, Timothy T. Houle, Grace E. Namirembe, Julia Bertsch, Alexis Novak
article en

Abstract

Objectives This study aimed to assess the enduring impact of cross-clamp duration on postoperative sleep disturbance and functional outcomes (up to 180 days) in cardiac surgery patients. Design This is a secondary analysis of data from a randomized, double-blind trial comparing dexmedetomidine to placebo for delirium prevention (Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep). Setting Data from patients recruited at a tertiary medical center in Boston, Massachusetts, between March 2017 and February 2022 were analyzed in January 2024. Participants The study included 394 patients aged ≥60 who underwent cardiac surgery with cardiopulmonary bypass. Interventions The primary exposure was cross-clamp time, while secondary exposures included surgical type [isolated coronary artery bypass graft (CABG) or not] and dexmedetomidine randomization. Measurements and main results The primary outcome was sleep quality, assessed using the PROMIS Sleep Disturbance questionnaire at 30, 90, and 180 days postoperatively. Secondary outcomes encompassed cognitive function and health-related quality of life in various domains. Sleep quality, measured by PROMIS scores, showed improvement over time, and did not differ based on cross-clamp duration (MD 0.74 points, 95% CI: −0.57, 2.07), procedure type (MD 2.14 points, 95% CI: 0.29, 3.99), or dexmedetomidine (MD 0.9 points, 95% CI: −1.33, 1.5). However, isolated CABG patients reported sleep disturbance at all time points. Notably, extended cross-clamp time (>90 min) significantly worsened the trajectories of mental health (90-day: MD −2.37 points, 95% CI: −4.35, −0.39; 180-day: MD −2.68 points, 95% CI: −4.62, −0.73) and applied cognition (180-day: MD: −2.59 points, 95% CI: −4.49, −0.68). Conclusion Regardless of the duration of the cross-clamp, sleep quality tends to improve over time following cardiac surgery. However, cross-clamp times that last longer than 90 min have been identified as a risk factor for self-reported declines in mental health and applied cognition.

Frontiers in AnesthesiologyVol. 3
Openalex Percentile: Top 99%
Intensive Care Unit Cognitive Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.